247 related articles for article (PubMed ID: 21590365)
21. Primary mediastinal (thymic) large B-cell lymphoma: a short review with brief discussion of mediastinal gray zone lymphoma.
Hutchinson CB; Wang E
Arch Pathol Lab Med; 2011 Mar; 135(3):394-8. PubMed ID: 21366467
[TBL] [Abstract][Full Text] [Related]
22. Clinical, pathological and genetic features of primary mediastinal large B-cell lymphomas and mediastinal gray zone lymphomas in children.
Oschlies I; Burkhardt B; Salaverria I; Rosenwald A; d'Amore ES; Szczepanowski M; Koch K; Hansmann ML; Stein H; Möller P; Reiter A; Zimmermann M; Rosolen A; Siebert R; Jaffe ES; Klapper W
Haematologica; 2011 Feb; 96(2):262-8. PubMed ID: 20971819
[TBL] [Abstract][Full Text] [Related]
23. Diagnostic utility of programmed cell death ligand 1 (clone SP142) in mediastinal composite lymphoma: A report of two cases.
Sakakibara A; Kohno K; Iwakoshi A; Moritani S; Fujishiro A; Kito K; Suzuki Y; Shimada S; Nakaguro M; Shimoyama Y; Takahara T; Takahashi E; Ohashi A; Satou A; Kato S; Asano N; Nakamura S
Pathol Int; 2020 Feb; 70(2):116-122. PubMed ID: 31894883
[TBL] [Abstract][Full Text] [Related]
24. Evolution in the definition and diagnosis of the Hodgkin lymphomas and related entities.
Tousseyn TA; King RL; Fend F; Feldman AL; Brousset P; Jaffe ES
Virchows Arch; 2023 Jan; 482(1):207-226. PubMed ID: 36274093
[TBL] [Abstract][Full Text] [Related]
25. Gene Expression Profiling of Mediastinal Gray Zone Lymphoma and Its Relationship to Primary Mediastinal B-cell Lymphoma and Classical Hodgkin Lymphoma.
Pittaluga S; Nicolae A; Wright GW; Melani C; Roschewski M; Steinberg S; Huang D; Staudt LM; Jaffe ES; Wilson WH
Blood Cancer Discov; 2020 Sep; 1(2):155-161. PubMed ID: 32914098
[TBL] [Abstract][Full Text] [Related]
26. Shades of gray between large B-cell lymphomas and Hodgkin lymphomas: differential diagnosis and biological implications.
Harris NL
Mod Pathol; 2013 Jan; 26 Suppl 1():S57-70. PubMed ID: 23281436
[TBL] [Abstract][Full Text] [Related]
27. Primary Mediastinal Nodal and Extranodal Non-Hodgkin Lymphomas: Current Concepts, Historical Evolution, and Useful Diagnostic Approach: Part 1.
Piña-Oviedo S; Moran CA
Adv Anat Pathol; 2019 Nov; 26(6):346-370. PubMed ID: 31567132
[TBL] [Abstract][Full Text] [Related]
28. Grey zone lymphoma with features intermediate between diffuse large B-cell lymphoma and classical Hodgkin lymphoma: a clinicopathological study of 14 Epstein-Barr virus-positive cases.
Elsayed AA; Satou A; Eladl AE; Kato S; Nakamura S; Asano N
Histopathology; 2017 Mar; 70(4):579-594. PubMed ID: 27735994
[TBL] [Abstract][Full Text] [Related]
29. Primary mediastinal B-cell lymphoma and mediastinal gray zone lymphoma: do they require a unique therapeutic approach?
Dunleavy K; Wilson WH
Blood; 2015 Jan; 125(1):33-9. PubMed ID: 25499450
[TBL] [Abstract][Full Text] [Related]
30. [Unclassified B-cell lymphomas with "grey zone" characteristics].
Chen DB; Shen DH
Zhonghua Bing Li Xue Za Zhi; 2011 Apr; 40(4):278-81. PubMed ID: 21616011
[No Abstract] [Full Text] [Related]
31. Primary Mediastinal Nodal and Extranodal Non-Hodgkin Lymphomas: Current Concepts, Historical Evolution, and Useful Diagnostic Approach: Part 2.
Piña-Oviedo S; Moran CA
Adv Anat Pathol; 2019 Nov; 26(6):371-389. PubMed ID: 31567129
[TBL] [Abstract][Full Text] [Related]
32. B-cell lymphoma, unclassifiable, with features intermediate between diffuse large B-cell lymphoma and classical Hodgkin lymphoma without mediastinal disease: mimicking nodular sclerosis classical Hodgkin lymphoma.
Iwaki N; Sato Y; Kurokawa T; Maeda Y; Ohno K; Takeuchi M; Takata K; Orita Y; Nakao S; Yoshino T
Med Mol Morphol; 2013 Sep; 46(3):172-6. PubMed ID: 23512149
[TBL] [Abstract][Full Text] [Related]
33. Expression of Grb2 distinguishes classical Hodgkin lymphomas from primary mediastinal B-cell lymphomas and other diffuse large B-cell lymphomas.
Miles RR; Mankey CC; Seiler CE; Smith LB; Teruya-Feldstein J; Hsi ED; Elenitoba-Johnson KS; Lim MS
Hum Pathol; 2009 Dec; 40(12):1731-7. PubMed ID: 19716163
[TBL] [Abstract][Full Text] [Related]
34. How I manage patients with grey zone lymphoma.
Kritharis A; Pilichowska M; Evens AM
Br J Haematol; 2016 Aug; 174(3):345-50. PubMed ID: 27301470
[TBL] [Abstract][Full Text] [Related]
35. Tumor microenvironment contribution to checkpoint blockade therapy: lessons learned from Hodgkin lymphoma.
Carbone A; Gloghini A; Carlo-Stella C
Blood; 2023 May; 141(18):2187-2193. PubMed ID: 36898085
[TBL] [Abstract][Full Text] [Related]
36. A first-in-class inhibitor of HSP110 to potentiate XPO1-targeted therapy in primary mediastinal B-cell lymphoma and classical Hodgkin lymphoma.
Durand M; Cabaud Gibouin V; Duplomb L; Salmi L; Caillot M; Sola B; Camus V; Jardin F; Garrido C; Jego G
J Exp Clin Cancer Res; 2024 May; 43(1):148. PubMed ID: 38773631
[TBL] [Abstract][Full Text] [Related]
37. The molecular signature of mediastinal large B-cell lymphoma differs from that of other diffuse large B-cell lymphomas and shares features with classical Hodgkin lymphoma.
Savage KJ; Monti S; Kutok JL; Cattoretti G; Neuberg D; De Leval L; Kurtin P; Dal Cin P; Ladd C; Feuerhake F; Aguiar RC; Li S; Salles G; Berger F; Jing W; Pinkus GS; Habermann T; Dalla-Favera R; Harris NL; Aster JC; Golub TR; Shipp MA
Blood; 2003 Dec; 102(12):3871-9. PubMed ID: 12933571
[TBL] [Abstract][Full Text] [Related]
38. Primary mediastinal large B-cell lymphoma: transcriptional regulation by miR-92a through FOXP1 targeting.
Romero M; Gapihan G; Castro-Vega LJ; Acevedo A; Wang L; Li ZW; El Bouchtaoui M; Di Benedetto M; Ratajczak P; Feugeas JP; Thieblemont C; Saavedra C; Janin A
Oncotarget; 2017 Mar; 8(10):16243-16258. PubMed ID: 27806315
[TBL] [Abstract][Full Text] [Related]
39. The spectrum of B-cell lymphoma, unclassifiable, with features intermediate between diffuse large B-cell lymphoma and classical Hodgkin lymphoma: a description of 10 cases.
Gualco G; Natkunam Y; Bacchi CE
Mod Pathol; 2012 May; 25(5):661-74. PubMed ID: 22222636
[TBL] [Abstract][Full Text] [Related]
40. Clinical Features and Therapeutic Outcomes Comparing Primary Mediastinal Large B-cell Lymphoma to Mediastinal Hodgkin Disease.
Cruz-Chamorro RJ; Rodríguez-López JL; González-Soto MJ; Arroyo-Suárez R; Ortiz-Sánchez C; Encarnación-Medina J; Cabanillas F
P R Health Sci J; 2024 Jun; 43(2):79-83. PubMed ID: 38860961
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
